Haartsen, Rianne
Charman, Tony
Pasco, Greg
Johnson, Mark H.
Jones, Emily J. H.
,
Baron-Cohen, Simon
Bedford, Rachael
Blasi, Anna
Bolton, Patrick
Chandler, Susie
Cheung, Celeste
Davies, Kim
Elsabbagh, Mayada
Fernandes, Janice
Gammer, Issy
Garwood, Holly
Gliga, Teadora
Guiraud, Jeanne
Hudry, Kirstelle
Liew, Melanie
Lloyd-Fox, Sarah
Maris, Helen
O’Hara, Louise
Pickles, Andrew
Ribeiro, Helen
Salomone, Erica
Tucker, Leslie
Volein, Agnes
Funding for this research was provided by:
Horizon 2020 Framework Programme (642990)
Horizon 2020 Framework Programme (642990)
Horizon 2020 Framework Programme (642990)
Horizon 2020 Framework Programme (642990)
the Birkbeck Wellcome Trust Institutional Strategic Support Fund (204770/Z/16/Z)
Innovative Medicines Initiative 2 Joint Undertaking (777394)
Innovative Medicines Initiative 2 Joint Undertaking (777394)
Innovative Medicines Initiative 2 Joint Undertaking (777394)
Innovative Medicines Initiative 2 Joint Undertaking (777394)
Innovative Medicines Initiative 2 Joint Undertaking (777394)
Innovative Medicines Initiative (115300)
Innovative Medicines Initiative (115300)
Innovative Medicines Initiative (115300)
Innovative Medicines Initiative (115300)
Medical Research Council (G0701484)
Medical Research Council (G0701484)
Medical Research Council (G0701484)
Medical Research Council (G0701484)
Article History
Received: 18 August 2022
Accepted: 22 November 2022
First Online: 1 December 2022
Competing interests
: The authors declare no competing interests.